A gene therapy recently approved by the FDA to treat patients with Sickle Cell Anemia is now being administered in St. Louis.

Doctors noticed that patients who had sickle cell anemia, a serious hereditary blood disease, were more likely to survive malaria, a disease which kills some 1.2 million people every year.

Can we predict that natural selection will weed out genetic disease over time? Sickle-cell trait haplotype distribution shows the genetic advantages of this mutation. In the deoxygenated ...

The Food and Drug Administration on Friday approved a powerful treatment for sickle cell disease ... warning — the strongest safety warning label— to Bluebird Bio’s Lyfgenia, noting that ...

It has been a medical mystery for 67 years, ever since the British geneticist Anthony Allison established that carriers of one mutated copy of the gene that causes sickle-cell anaemia are ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with sickle cell disease ... improving anemia, and reducing the risk of ...

In a form of sickle cell disease called sickle cell anemia, mutations in a gene called HBB affect the protein’s structure, causing it to twist normally round red blood cells into a curved sickle ...